Biogen’s New Boss Is Delivering, but Stock Isn’t Pricing It in Yet
The decision to buy Reata signals a new era under CEO Chris Viehbacher, and Wall Street’s skepticism presents an opportunity.
Monday, June 1, 2026
Tag: Chris Viehbacher
EP NEWSROOM
© 2025 Edinburg Post or its affiliated companies.